Literature DB >> 30789059

Can acceptance and commitment therapy facilitate psychological adjustment after a severe traumatic brain injury? A pilot randomized controlled trial.

Diane Whiting1,2, Frank Deane2, Hamish McLeod3, Joseph Ciarrochi4, Grahame Simpson1,5.   

Abstract

This study i⁠nvestigated if an Acceptance and Commitment Therapy (ACT) intervention (ACT-Adjust) can facilitate psychological adjustment and reduce psychological distress following severe traumatic brain injury (TBI). The study design comprised a single centre, two-armed, Phase II pilot randomized controlled trial. Nineteen individuals with severe TBI (PTA ≥7 days) who met a clinical threshold for psychological distress (Depression Anxiety Stress Scales-21; DASS > 9) were randomly allocated to either ACT-Adjust (n = 10) or an active control, Befriending Therapy (n = 9), in conjunction with a holistic rehabilitation programme. Primary (psychological flexibility, rehabilitation participation) and secondary (depression, anxiety & stress) outcomes were measured at three-time points (pre, post and follow up). Significant decreases were found for DASS-depression (group by time interaction, F 1,17 = 5.35, p = .03) and DASS-stress (group by time interaction, F 1,17 = 5.69, p = .03) in comparison to the Befriending group, but not for the primary outcome measures. The reduction in stress post-treatment was classed as clinically significant, however interaction differences for stress and depression were not maintained at one month follow up. Preliminary investigations indicate potential for ACT in decreasing psychological distress for individuals with a severe TBI with further sessions required to maintain treatment gains. The pilot results suggest further investigation is warranted in a larger scale clinical trial.

Entities:  

Keywords:  Acceptance and commitment therapy; Anxiety; Depression; Psychological flexibility; Randomized controlled trial; Stress; Traumatic brain injury

Mesh:

Year:  2019        PMID: 30789059     DOI: 10.1080/09602011.2019.1583582

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  6 in total

1.  Acceptance and Commitment Training for Veterans with Polytrauma: A randomized controlled trial protocol.

Authors:  Alex Uzdavines; Raquel D Gonzalez; Alexandra Price; Dakota Broadway; Tracey L Smith; Merlyn Rodrigues; Ken Woods; M Bridget Zimmerman; Ricardo Jorge; Lilian Dindo
Journal:  Contemp Clin Trials       Date:  2021-10-21       Impact factor: 2.226

2.  Enhancing Self-Advocacy After Traumatic Brain Injury: A Randomized Controlled Trial.

Authors:  Lenore Hawley; Clare Morey; Mitch Sevigny; Jessica Ketchum; Grahame Simpson; Cynthia Harrison-Felix; Candace Tefertiller
Journal:  J Head Trauma Rehabil       Date:  2022 Mar-Apr 01       Impact factor: 3.117

3.  A systematic review on integrated care for traumatic brain injury, mental health, and substance use.

Authors:  Vincy Chan; Danielle Toccalino; Samira Omar; Riya Shah; Angela Colantonio
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

4.  Does Integrating Cognitive and Psychological Interventions Enhance Wellbeing After Acquired Brain Injury? Study Protocol for a Phase II Randomized Controlled Trial of the VaLiANT (Valued Living After Neurological Trauma) Group Program.

Authors:  Nick Sathananthan; Eric M J Morris; David Gillanders; Lucy Knox; Bleydy Dimech-Betancourt; Bradley J Wright; Roshan das Nair; Dana Wong
Journal:  Front Rehabil Sci       Date:  2022-01-21

5.  Psychotherapeutic Intervention for Adults With Acquired Brain Injury: A Case Study Using BackUp.

Authors:  Cecilie Marie S Thøgersen; Chalotte Glintborg; Tia G B Hansen; Johan Trettvik
Journal:  Front Rehabil Sci       Date:  2022-02-18

6.  The BrainACT study: acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury: study protocol for a randomized controlled trial.

Authors:  Johanne Rauwenhoff; Frenk Peeters; Yvonne Bol; Caroline Van Heugten
Journal:  Trials       Date:  2019-12-27       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.